First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-09-18 02:00:41Open Document File Size: 245,81 KBShare Result on FacebookCountryUnited States / Canada / /FacilityHCV Drug pipeline / /IndustryTermmain replication site / treatment of HCV / HCV therapy / printing presses / food / /MedicalConditionHIV / HBV / hepatitis C / HCV / virus infection / diseases / Benefits Column ¾¾ Hepatitis B / hepatitis C. We / hepatitis C. It / /PersonAlan Franciscus Webmaster / C.D. Mazoff / Lucinda K. Porter / /PositionEditor-in-Chief / ¾¾ HCV Advocate / BASICS Executive Director / HCV Advocate / HBV Advocate / Webmaster / /Productribavirin / peginterferon / /URLwww.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html / www.hcvadvocate.org / www.clinicaltrials.gov / /SocialTag |